CAPR — Capricor Therapeutics, Inc. stock price, charts and financials

QT15Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
4.17
-0.03-0.71%
OverviewShort InterestFilings
CAPRQT15Capricor Therapeutics, Inc.·NASDAQ
4.17-0.71%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 03, 2026SC 13GBeneficial ownership statement (passive)
Jul 30, 20268-KCurrent report
Jul 29, 20268-KCurrent report
Jul 14, 20268-KCurrent report
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 26, 20268-KCurrent report
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 08, 20268-KCurrent report
May 28, 20264Statement of changes in beneficial ownership
May 28, 20263Initial statement of beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 14, 20264Statement of changes in beneficial ownership
May 13, 202610-QQuarterly report
May 12, 20268-KCurrent report
May 07, 20268-KCurrent report
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
Apr 10, 2026DEF 14ADefinitive proxy statement
Apr 10, 2026ARSAnnual report to shareholders
Apr 03, 20264Statement of changes in beneficial ownership
Apr 01, 20264Statement of changes in beneficial ownership
Apr 01, 20264Statement of changes in beneficial ownership
Apr 01, 20264Statement of changes in beneficial ownership
#1 / 25 of 243
Page
▼
/ 10